BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35163171)

  • 1. The Wnt Signaling Pathway Inhibitors Improve the Therapeutic Activity of Glycolysis Modulators against Tongue Cancer Cells.
    Kleszcz R; Paluszczak J
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combinatorial inhibition of Wnt signaling and Akt kinase is beneficial for reducing the survival and glycolytic activity of tongue cancer cells.
    Kleszcz R; Paluszczak J
    J Oral Pathol Med; 2022 Mar; 51(3):231-239. PubMed ID: 34358376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of CBP/β-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells.
    Kleszcz R; Szymańska A; Krajka-Kuźniak V; Baer-Dubowska W; Paluszczak J
    Cell Oncol (Dordr); 2019 Aug; 42(4):505-520. PubMed ID: 31089983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinations of PRI-724 Wnt/β-Catenin Pathway Inhibitor with Vismodegib, Erlotinib, or HS-173 Synergistically Inhibit Head and Neck Squamous Cancer Cells.
    Kleszcz R; Frąckowiak M; Dorna D; Paluszczak J
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRI-724 and IWP-O1 Wnt Signaling Pathway Inhibitors Modulate the Expression of Glycolytic Enzymes in Tongue Cancer Cell Lines.
    Kleszcz R; Paluszczak J; Belka M; Krajka-Kuźniak V
    Curr Issues Mol Biol; 2023 Nov; 45(12):9579-9592. PubMed ID: 38132445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor for advanced glycation end product blockade enhances the chemotherapeutic effect of cisplatin in tongue squamous cell carcinoma by reducing autophagy and modulating the Wnt pathway.
    Zhao Z; Wang H; Zhang L; Mei X; Hu J; Huang K
    Anticancer Drugs; 2017 Feb; 28(2):187-196. PubMed ID: 27831944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines.
    Schmidtova S; Kalavska K; Liskova V; Plava J; Miklikova S; Kucerova L; Matuskova M; Rojikova L; Cierna Z; Rogozea A; Konig H; Albany C; Mego M; Chovanec M
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner.
    Wiese M; Walther N; Diederichs C; Schill F; Monecke S; Salinas G; Sturm D; Pfister SM; Dressel R; Johnsen SA; Kramm CM
    Oncotarget; 2017 Apr; 8(16):27300-27313. PubMed ID: 28460484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice.
    Okazaki H; Sato S; Koyama K; Morizumi S; Abe S; Azuma M; Chen Y; Goto H; Aono Y; Ogawa H; Kagawa K; Nishimura H; Kawano H; Toyoda Y; Uehara H; Kouji H; Nishioka Y
    Exp Lung Res; 2019 Sep; 45(7):188-199. PubMed ID: 31298961
    [No Abstract]   [Full Text] [Related]  

  • 10. Dual targeting of Notch and Wnt/β-catenin pathways: Potential approach in triple-negative breast cancer treatment.
    Nasser F; Moussa N; Helmy MW; Haroun M
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Mar; 394(3):481-490. PubMed ID: 33052427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor Activity of the Small Molecule Inhibitor PRI-724 Against β-Catenin-activated Hepatocellular Carcinoma.
    Gabata R; Harada K; Mizutani Y; Ouchi H; Yoshimura K; Sato Y; Kitao A; Kimura K; Kouji H; Miyashita T; Tajima H; Ohta T
    Anticancer Res; 2020 Sep; 40(9):5211-5219. PubMed ID: 32878809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma.
    Lin HH; Feng WC; Lu LC; Shao YY; Hsu CH; Cheng AL
    Cancer Lett; 2016 Oct; 381(1):58-66. PubMed ID: 27431312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
    Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
    Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy-Induced Long Non-coding RNA 1 Promotes Metastasis and Chemo-Resistance of TSCC via the Wnt/β-Catenin Signaling Pathway.
    Lin Z; Sun L; Xie S; Zhang S; Fan S; Li Q; Chen W; Pan G; Wang W; Weng B; Zhang Z; Liu B; Li J
    Mol Ther; 2018 Jun; 26(6):1494-1508. PubMed ID: 29699939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aerobic glycolysis activation through canonical WNT/β-catenin pathway in ALS].
    Vallée A
    Med Sci (Paris); 2018 Apr; 34(4):326-330. PubMed ID: 29658475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors.
    Ayadi M; Bouygues A; Ouaret D; Ferrand N; Chouaib S; Thiery JP; Muchardt C; Sabbah M; Larsen AK
    Oncotarget; 2015 Jul; 6(21):18518-33. PubMed ID: 26041882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of the long non-coding RNA AFAP1-AS1 affects the proliferation, invasion and survival of tongue squamous cell carcinoma via the Wnt/β-catenin signaling pathway.
    Wang ZY; Hu M; Dai MH; Xiong J; Zhang S; Wu HJ; Zhang SS; Gong ZJ
    Mol Cancer; 2018 Jan; 17(1):3. PubMed ID: 29310682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA-binding motif protein 5 negatively regulates the activity of Wnt/β-catenin signaling in cigarette smoke-induced alveolar epithelial injury.
    Hao YQ; Su ZZ; Lv XJ; Li P; Gao P; Wang C; Bai Y; Zhang J
    Oncol Rep; 2015 May; 33(5):2438-44. PubMed ID: 25738917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.
    Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y
    Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Label-Free Quantitative Proteomics Combined with Biological Validation Reveals Activation of Wnt/β-Catenin Pathway Contributing to Trastuzumab Resistance in Gastric Cancer.
    Liu W; Yuan J; Liu Z; Zhang J; Chang J
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.